Alan R Branfman

Title: The Innovative Mind of Alan R. Branfman: A Look at His Contributions

Introduction

Alan R. Branfman is a notable inventor based in Cherry Hill, NJ, known for his contributions to the field of pharmaceuticals. With two patents to his name, Branfman has made significant advancements in the formulation of ibuprofen, enhancing its stability and usability in medicinal preparations.

Latest Patents

Branfman's latest patents focus on improving ibuprofen formulations. The first patent, titled "Inhibition of Thermal Degradation of Ibuprofen", introduces a method to stabilize ibuprofen and its pharmaceutical preparations against thermal degradation through the use of a phenolic-type antioxidant. This innovation is significant as it enhances the efficacy and shelf-life of ibuprofen-containing medications.

The second patent, "Acid Addition Salt of Ibuprofen and Meglumine", details the preparation of a water-soluble salt of ibuprofen using meglumine (N-methylglucamine). Branfman's work includes isolating and characterizing this salt, leading to the development of pharmaceutical preparations that are clear and pleasant-tasting liquids for oral administration. These advancements contribute greatly to the user experience and accessibility of ibuprofen.

Career Highlights

Alan R. Branfman has built a robust career at American Home Products Corporation, where he has leveraged his expertise in pharmaceutical innovations. His tenure at the company has seen him actively engaged in research and development, particularly in the area of drug formulation.

Collaborations

Throughout his career, Branfman has collaborated with esteemed colleagues, including Solomon Motola and Gary R. Agisim. These partnerships have fostered a creative environment that encourages innovation, leading to the development of his significant patents and contributions to the pharmaceutical sector.

Conclusion

Alan R. Branfman's inventive spirit and commitment to pharmaceutical research have led to impactful innovations in ibuprofen formulations. His work demonstrates the importance of continuous development in the pharmaceutical industry, ultimately benefiting consumers and healthcare providers alike.